Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 3 | 2019 | 171 | 1.130 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2022 | 1157 | 0.990 |
Why?
|
| Cerebral Hemorrhage | 5 | 2022 | 108 | 0.850 |
Why?
|
| Blood Glucose | 2 | 2020 | 99 | 0.820 |
Why?
|
| Brain Mapping | 6 | 2021 | 171 | 0.810 |
Why?
|
| Biomarkers | 3 | 2020 | 556 | 0.710 |
Why?
|
| Neuregulins | 1 | 2019 | 1 | 0.680 |
Why?
|
| Headache | 1 | 2019 | 33 | 0.670 |
Why?
|
| Mean Platelet Volume | 1 | 2018 | 1 | 0.640 |
Why?
|
| Diabetic Nephropathies | 1 | 2018 | 22 | 0.630 |
Why?
|
| Lymphocytes | 1 | 2018 | 59 | 0.620 |
Why?
|
| Circle of Willis | 1 | 2017 | 5 | 0.570 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 26 | 0.560 |
Why?
|
| Sclerosis | 1 | 2017 | 67 | 0.560 |
Why?
|
| Temporal Lobe | 1 | 2017 | 85 | 0.550 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2022 | 90 | 0.520 |
Why?
|
| Thalamus | 4 | 2021 | 23 | 0.510 |
Why?
|
| Middle Aged | 22 | 2021 | 8601 | 0.500 |
Why?
|
| Female | 28 | 2021 | 14539 | 0.500 |
Why?
|
| Adult | 22 | 2021 | 7448 | 0.500 |
Why?
|
| Humans | 44 | 2022 | 26286 | 0.500 |
Why?
|
| Image Enhancement | 2 | 2020 | 46 | 0.500 |
Why?
|
| Male | 27 | 2021 | 14162 | 0.450 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2021 | 67 | 0.450 |
Why?
|
| Brain | 6 | 2021 | 1643 | 0.430 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 69 | 0.400 |
Why?
|
| Diagnostic Imaging | 2 | 2020 | 72 | 0.380 |
Why?
|
| Aged | 15 | 2021 | 8765 | 0.360 |
Why?
|
| Brain Ischemia | 2 | 2021 | 60 | 0.340 |
Why?
|
| Evoked Potentials, Motor | 1 | 2009 | 11 | 0.330 |
Why?
|
| Motor Cortex | 1 | 2009 | 14 | 0.320 |
Why?
|
| Young Adult | 6 | 2021 | 1886 | 0.320 |
Why?
|
| Brain Diseases | 1 | 2009 | 65 | 0.310 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 110 | 0.310 |
Why?
|
| Graft Rejection | 2 | 2018 | 63 | 0.290 |
Why?
|
| Contrast Media | 3 | 2020 | 60 | 0.290 |
Why?
|
| Liver Transplantation | 2 | 2018 | 65 | 0.280 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 853 | 0.270 |
Why?
|
| Auditory Cortex | 1 | 2005 | 3 | 0.260 |
Why?
|
| Case-Control Studies | 4 | 2021 | 566 | 0.260 |
Why?
|
| Risk Factors | 7 | 2021 | 2265 | 0.250 |
Why?
|
| Language | 1 | 2005 | 62 | 0.250 |
Why?
|
| Sex Characteristics | 1 | 2005 | 120 | 0.230 |
Why?
|
| Postoperative Complications | 3 | 2020 | 869 | 0.230 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 76 | 0.230 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2008 | 26 | 0.210 |
Why?
|
| Turkey | 2 | 2018 | 5 | 0.200 |
Why?
|
| Radiology | 1 | 2021 | 16 | 0.190 |
Why?
|
| Encephalocele | 1 | 2021 | 24 | 0.190 |
Why?
|
| Retrospective Studies | 9 | 2021 | 3367 | 0.190 |
Why?
|
| Patient Care Planning | 1 | 2001 | 51 | 0.190 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 40 | 0.190 |
Why?
|
| Glioma | 1 | 2021 | 19 | 0.180 |
Why?
|
| Thyroid Neoplasms | 2 | 2017 | 30 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 87 | 0.180 |
Why?
|
| Adenolymphoma | 1 | 2020 | 4 | 0.180 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2020 | 6 | 0.180 |
Why?
|
| Antiviral Agents | 1 | 2021 | 69 | 0.180 |
Why?
|
| Kidney Neoplasms | 1 | 2001 | 66 | 0.180 |
Why?
|
| Facial Nerve | 1 | 2020 | 13 | 0.180 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2020 | 21 | 0.180 |
Why?
|
| Parotid Gland | 1 | 2020 | 16 | 0.180 |
Why?
|
| Dissection | 1 | 2020 | 22 | 0.180 |
Why?
|
| Parotid Neoplasms | 1 | 2020 | 14 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2020 | 28 | 0.180 |
Why?
|
| Nerve Net | 1 | 2021 | 47 | 0.180 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 6 | 0.180 |
Why?
|
| Gray Matter | 1 | 2021 | 55 | 0.180 |
Why?
|
| Hospital Mortality | 1 | 2021 | 136 | 0.180 |
Why?
|
| Artifacts | 1 | 2020 | 33 | 0.180 |
Why?
|
| Kidney | 1 | 2001 | 156 | 0.180 |
Why?
|
| Fasting | 1 | 2019 | 13 | 0.170 |
Why?
|
| Hernia | 1 | 2019 | 9 | 0.170 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 91 | 0.170 |
Why?
|
| White Matter | 2 | 2019 | 142 | 0.170 |
Why?
|
| Brain Edema | 1 | 2019 | 20 | 0.170 |
Why?
|
| Neuroma, Acoustic | 1 | 2019 | 9 | 0.170 |
Why?
|
| Movement | 1 | 2020 | 110 | 0.170 |
Why?
|
| Emergencies | 1 | 2019 | 34 | 0.170 |
Why?
|
| Acute Disease | 2 | 2019 | 192 | 0.170 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 164 | 0.170 |
Why?
|
| Sarcoidosis | 1 | 2019 | 13 | 0.170 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 16 | 0.170 |
Why?
|
| Recovery of Function | 1 | 2020 | 283 | 0.160 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 7 | 0.160 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 9 | 0.160 |
Why?
|
| Spinal Cord Diseases | 1 | 2019 | 49 | 0.160 |
Why?
|
| Stomach | 1 | 2018 | 13 | 0.160 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 16 | 0.160 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 29 | 0.160 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 35 | 0.160 |
Why?
|
| Obesity, Abdominal | 1 | 2018 | 19 | 0.160 |
Why?
|
| Adiposity | 1 | 2019 | 38 | 0.160 |
Why?
|
| Weight Gain | 1 | 2019 | 61 | 0.160 |
Why?
|
| Brain Abscess | 1 | 2018 | 5 | 0.160 |
Why?
|
| Intra-Abdominal Fat | 1 | 2018 | 39 | 0.160 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 9 | 0.160 |
Why?
|
| Intracranial Pressure | 1 | 2018 | 12 | 0.160 |
Why?
|
| Adolescent | 4 | 2020 | 2080 | 0.150 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 153 | 0.150 |
Why?
|
| Pediatric Obesity | 1 | 2019 | 47 | 0.150 |
Why?
|
| Nerve Fibers | 1 | 2018 | 13 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 18 | 0.150 |
Why?
|
| Walking | 1 | 2020 | 257 | 0.150 |
Why?
|
| Child Development | 1 | 2019 | 73 | 0.150 |
Why?
|
| Spinal Diseases | 1 | 2019 | 114 | 0.150 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 133 | 0.150 |
Why?
|
| Pregnancy | 1 | 2019 | 310 | 0.150 |
Why?
|
| Thyroid Nodule | 1 | 2017 | 4 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 186 | 0.150 |
Why?
|
| Erythrocyte Indices | 1 | 2017 | 5 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2018 | 102 | 0.150 |
Why?
|
| Biliary Tract | 1 | 2017 | 2 | 0.150 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2017 | 3 | 0.150 |
Why?
|
| Cysts | 1 | 2017 | 15 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 191 | 0.140 |
Why?
|
| Anastomosis, Surgical | 1 | 2017 | 26 | 0.140 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 26 | 0.140 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 10 | 0.140 |
Why?
|
| Calcinosis | 1 | 2017 | 47 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 230 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 723 | 0.140 |
Why?
|
| Epithalamus | 1 | 2016 | 3 | 0.140 |
Why?
|
| Afferent Pathways | 1 | 2016 | 5 | 0.140 |
Why?
|
| Functional Laterality | 1 | 2017 | 65 | 0.140 |
Why?
|
| Sensitivity and Specificity | 4 | 2022 | 485 | 0.140 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 354 | 0.140 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 4675 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 177 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2021 | 1668 | 0.130 |
Why?
|
| Cervical Vertebrae | 1 | 2019 | 301 | 0.130 |
Why?
|
| Child | 3 | 2021 | 1236 | 0.130 |
Why?
|
| Radiopharmaceuticals | 2 | 2010 | 49 | 0.130 |
Why?
|
| Stroke | 1 | 2018 | 260 | 0.120 |
Why?
|
| Dominance, Cerebral | 2 | 2005 | 15 | 0.120 |
Why?
|
| Corpus Callosum | 2 | 2019 | 11 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2020 | 480 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2006 | 218 | 0.110 |
Why?
|
| Prognosis | 3 | 2020 | 758 | 0.100 |
Why?
|
| Parkinson Disease | 2 | 2018 | 842 | 0.100 |
Why?
|
| Time Factors | 3 | 2020 | 1391 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 1738 | 0.090 |
Why?
|
| Aging | 1 | 2019 | 1538 | 0.090 |
Why?
|
| Dementia, Vascular | 1 | 2010 | 45 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 460 | 0.080 |
Why?
|
| Neuroradiography | 1 | 2009 | 2 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 347 | 0.080 |
Why?
|
| Pediatrics | 1 | 2009 | 32 | 0.080 |
Why?
|
| Subclavian Artery | 1 | 2008 | 3 | 0.080 |
Why?
|
| Vertebral Artery | 1 | 2008 | 4 | 0.080 |
Why?
|
| Reference Values | 1 | 2009 | 184 | 0.080 |
Why?
|
| Echo-Planar Imaging | 2 | 2005 | 4 | 0.080 |
Why?
|
| Hospitalization | 2 | 2021 | 294 | 0.080 |
Why?
|
| Thallium Radioisotopes | 3 | 1999 | 5 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2009 | 378 | 0.070 |
Why?
|
| Technetium Tc 99m Sestamibi | 3 | 1999 | 10 | 0.070 |
Why?
|
| Graft Survival | 2 | 2018 | 90 | 0.070 |
Why?
|
| Organotechnetium Compounds | 3 | 1999 | 8 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2021 | 629 | 0.070 |
Why?
|
| Survival Rate | 2 | 2018 | 322 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 679 | 0.070 |
Why?
|
| Body Mass Index | 2 | 2019 | 427 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2006 | 71 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1343 | 0.060 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2003 | 14 | 0.050 |
Why?
|
| Frontal Sinus | 1 | 2003 | 13 | 0.050 |
Why?
|
| Aphasia, Broca | 1 | 2003 | 2 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2003 | 8 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2003 | 13 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2003 | 13 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 39 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2019 | 593 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2003 | 81 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2021 | 3391 | 0.050 |
Why?
|
| Blindness | 1 | 2022 | 12 | 0.050 |
Why?
|
| Iliac Artery | 1 | 2001 | 5 | 0.050 |
Why?
|
| Renal Artery | 1 | 2001 | 6 | 0.050 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2021 | 3 | 0.050 |
Why?
|
| Petrous Bone | 1 | 2021 | 5 | 0.050 |
Why?
|
| Pelvis | 1 | 2001 | 30 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 437 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 24 | 0.050 |
Why?
|
| Equipment Failure | 1 | 2020 | 37 | 0.050 |
Why?
|
| Fatigue | 1 | 2020 | 56 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 2019 | 12 | 0.040 |
Why?
|
| Caudate Nucleus | 1 | 2019 | 11 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 41 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2020 | 95 | 0.040 |
Why?
|
| Radionuclide Imaging | 5 | 1999 | 42 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 450 | 0.040 |
Why?
|
| Spine | 1 | 2020 | 111 | 0.040 |
Why?
|
| Carcinoma, Medullary | 1 | 1999 | 6 | 0.040 |
Why?
|
| Ileum | 1 | 2018 | 15 | 0.040 |
Why?
|
| Tennessee | 1 | 2018 | 9 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 1998 | 10 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 130 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 2018 | 9 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 1998 | 22 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2018 | 22 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 57 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 137 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 47 | 0.040 |
Why?
|
| Intestines | 1 | 1998 | 94 | 0.040 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 55 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2017 | 7 | 0.040 |
Why?
|
| Smoking | 1 | 2018 | 170 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 126 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2018 | 122 | 0.040 |
Why?
|
| Infant | 1 | 2019 | 520 | 0.040 |
Why?
|
| Habenula | 1 | 2016 | 3 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 304 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 593 | 0.030 |
Why?
|
| Mothers | 1 | 2019 | 174 | 0.030 |
Why?
|
| Exercise | 1 | 2020 | 451 | 0.030 |
Why?
|
| Succimer | 1 | 1995 | 1 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1995 | 2 | 0.030 |
Why?
|
| Hemangioma | 1 | 1995 | 8 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 621 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 66 | 0.030 |
Why?
|
| Thymoma | 1 | 1995 | 7 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 1995 | 9 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 339 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1995 | 11 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 1995 | 7 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 333 | 0.030 |
Why?
|
| Sugar Acids | 1 | 1994 | 2 | 0.030 |
Why?
|
| Behcet Syndrome | 1 | 1994 | 4 | 0.030 |
Why?
|
| Uveitis | 1 | 1994 | 10 | 0.030 |
Why?
|
| United States | 1 | 2019 | 1990 | 0.030 |
Why?
|
| Arteritis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Aneurysm | 1 | 2008 | 10 | 0.020 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 1999 | 2 | 0.020 |
Why?
|
| Medical Illustration | 1 | 2006 | 14 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 36 | 0.010 |
Why?
|
| Research Design | 1 | 2003 | 183 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 315 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1999 | 5 | 0.010 |
Why?
|
| Calcitonin | 1 | 1999 | 16 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1998 | 2 | 0.010 |
Why?
|
| Parasympathomimetics | 1 | 1998 | 4 | 0.010 |
Why?
|
| Neostigmine | 1 | 1998 | 4 | 0.010 |
Why?
|
| Peristalsis | 1 | 1998 | 12 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 32 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 80 | 0.010 |
Why?
|
| Morphine | 1 | 1998 | 62 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1999 | 56 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 117 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1999 | 179 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 618 | 0.010 |
Why?
|
| Parathyroid Neoplasms | 1 | 1995 | 5 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1995 | 32 | 0.010 |
Why?
|
| Adenoma | 1 | 1995 | 43 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 507 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 222 | 0.010 |
Why?
|
| Animals | 1 | 1998 | 3538 | 0.010 |
Why?
|